Water-soluble lipopolymer as a gene carrier to corpus cavernosum

International Journal of Impotence Research

Volumn 17, Issue 4, 2005, Pages 326-334

  Lee, M ^a   Ryu, J K ^a   Oh, S M ^a   Lee, E ^a   Shin, H Y ^a   Song, S U ^a   Kim, S W ^b   Suh, J K ^a  

^a Inha University School of Medicine   (South Korea)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Erectile dysfunction; Gene delivery; Penis; Water soluble lipopolymer

Indexed keywords

ADENOVIRUS VECTOR; NAKED DNA; PLASMID DNA; POLYETHYLENEIMINE; POLYMER; UNCLASSIFIED DRUG; WATER SOLUBLE LIPOPOLYMER;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPLEX FORMATION; CORPUS CAVERNOSUM; CYTOTOXICITY; DNA TRANSFECTION; DOSE RESPONSE; ERECTILE DYSFUNCTION; GENE EXPRESSION; GENE THERAPY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RAT; RISK ASSESSMENT; SAFETY; SMOOTH MUSCLE FIBER; SOLUBILITY;

ADULT; CELLS, CULTURED; GENE DOSAGE; GENE EXPRESSION; GENE THERAPY; HUMANS; IMPOTENCE; LIPIDS; MALE; MYOCYTES, SMOOTH MUSCLE; PENIS; POLYETHYLENEIMINE; TRANSFECTION;

EID: 22644431808     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901314     Document Type: Article

References (33)

1. Edelstein ML, Abedi MR, Wixon J, Edelstein RM. Gene therapy clinical trials worldwide 1989-2004-an overview. J Gene Med 2004; 6: 597-602.
2. Wilson JM. Adenoviruses as gene-delivery vehicles. N Engl J Med 1996; 334: 1185-1187.
3. Kabanov AV, Kabanov VA. DNA complexes with polycations for the delivery of genetic material into cells. Bioconjug Chem 1995; 6: 7-20.
4. Temin HM. Safety considerations in somatic gene therapy of human disease with retrovirus vectors. Hum Gene Ther 1990; 1: 111-123.
5. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239-4242.
6. Cotton M, Wagner E. Non-viral approaches to gene therapy. Curr Opin Biotechnol 1993; 4: 705-710.
7. Lee M, Kim SW. Polymeric gene carriers. Pharm News 2002; 9: 407-415.
8. Champion HC et al. Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci USA 1999; 96: 11648-11652.
9. Bivalacqua TJ et al. Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat. Int J Impot Res 2000; 12(Suppl 3): S8-S17.
10. Tirney S et al. Nitric oxide synthase gene therapy for erectile dysfunction: comparison of plasmid, adenovirus, and adenovirus-transduced myoblast vectors. Mol Urol 2001; 5: 37-43.
11. Magee TR et al. Gene therapy of erectile dysfunction in the rat with penile neuronal nitric oxide synthase. Biol Reprod 2002; 67: 1033-1041.
12. Bivalacqua TJ et al. Gene transfer of endothelial nitric oxide synthase partially restores nitric oxide synthesis and erectile function in streptozotocin diabetic rats. J Urol 2003; 169: 1911-1917.
13. Chancellor MB et al. Nitric oxide synthase gene transfer for erectile dysfunction in a rat model. Br J Urol Int 2003; 91: 691-696.
14. Bivalacqua TJ et al. Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats. Int J Impot Res 2004; 16: 21-29.
15. Bivalacqua TJ et al. Gene transfer of prepro-calcitonin gene-related peptide restores erectile function in the aged rat. Biol Reprod 2001; 65: 1371-1377.
16. Lee MC et al. The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction. J Urol 2002; 167: 761-767.
17. Gholami SS et al. The effect of vascular endothelial growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and vasculogenic erectile dysfunction induced by hyperlipidemia. J Urol 2003; 169: 1577-1581.
18. Rogers RS et al. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 2003; 15: 26-37.
19. Christ GJ et al. Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function. Am J Physiol 1998; 275: H600-H608.
20. Melman A et al. The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo. J Urol 2003; 170: 285-290.
21. Abdallah B et al. A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther 1996; 7: 1947-1954.
22. Godbey WT, Wu KK, Mikos AG. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 1999; 45: 268-275.
23. Benns JM et al. Folate-PEG-folate-graft-polyethylenimine-based gene delivery. J Drug Target 2001; 9: 123-139.
24. Han S, Mahato RI, Kim SW. Water-soluble lipopolymer for gene delivery. Bioconjug Chem 2001; 12: 337-345.
25. Lee M et al. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium. Gene Therapy 2003; 10: 585-593.
26. Lee M, Han S, Ko KS, Kim SW. Cell type specific and glucose responsive expression of interleukin-4 by using insulin promoter and water soluble lipopolymer. J Control Release 2001; 75: 421-429.
27. Mahato RI et al. Intratumoral delivery of p2CMVmIL-12 using water-soluble lipopolymers. Mol Ther 2001; 4: 130-138.
28. 1 in human corpus cavernosum smooth muscle. J Urol 1995; 153: 826-834.
29. Lemkine GF et al. Optimisation of polyethylenimine-based gene delivery to mouse brain. J Drug Target 1999; 7: 305-312.
30. Turunen MP et al. Efficient adventitial gene delivery to rabbit carotid artery with cationic polymer-plasmid complexes. Gene Therapy 1999; 6: 6-11.
31. Wightman L, Patzelt E, Wagner E, Kircheis R. Development of transferrin-polycation/DNA based vectors for gene delivery to melanoma cells. J Drug Target 1999; 7: 293-303.
32. Nguyen HK et al. Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Therapy 2000; 7: 126-138.
33. Lee M et al. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm Res 2001; 18: 427-431.